Ligand Pharmaceuticals | LGND - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Agenus USD 58.98M 12.1M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
Baxter International USD 1.03B 52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Enviri Corporation USD 257.33M 17.68M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Heron Therapeutics USD 11.64M 2.67M 2026-06
Insmed USD 74.55M 1.18M 2026-06
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
MacroGenics USD 3.44M 845K 2026-06
Merck USD 3.83B 36M 2026-06
Pacira USD 17.51M 3.5M 2026-06
Pfizer USD 4.58B 75M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Veracyte USD 8.02M 1.12M 2026-06